Dutetrabenazine regulatory update

FDA granted Orphan Drug designation to Auspex’s SD-809 to treat Huntington’s disease (HD). The deuterium-substituted analog of tetrabenazine, a vesicular monoamine, is in Phase III testing to treat ch...